Alisa Miriam Goldstein

Title: Alisa Miriam Goldstein: Innovator in Tumor Suppressor Research

Introduction

Alisa Miriam Goldstein is a prominent inventor based in Rockville, MD (US). She has made significant contributions to the field of cancer research, particularly in the area of tumor suppressor genes. With a total of 2 patents, her work has the potential to impact the understanding and treatment of basal cell carcinoma.

Latest Patents

Goldstein's latest patents focus on the basal cell carcinoma tumor suppressor protein. Her first invention provides for a tumor suppressor gene inactivation, which is a causal factor in nevoid basal cell carcinoma syndrome and various sporadic basal cell carcinomas. The NBCCS gene is a homologue of the patched (ptc) gene. Her second patent also addresses the basal cell carcinoma tumor suppressor gene, reiterating the importance of this gene in the context of cancer research.

Career Highlights

Goldstein is associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. Her work in this esteemed organization highlights her commitment to advancing health and medical research.

Collaborations

Some of her notable coworkers include Michael C. Dean and Heidi Eve Hahn. Their collaborative efforts contribute to the innovative research environment in which Goldstein operates.

Conclusion

Alisa Miriam Goldstein's contributions to tumor suppressor research are invaluable. Her patents and work with the Department of Health and Human Services underscore her role as a leading inventor in the field.